Drug Standards
Medchemexpress LLC Fostamatinib disodium hexahydrate | 914295-16-2 | 99.5% | 50 MG
Fostamatinib disodium hexahydrate is an oral proagent of the active compound R406. R406 is an orally available and competitive Syk/FLT3 inhibitor, also inhibiting Lyn and Lck. This product is for research use only.
- Oral proagent of R406
- Orally available
- Competitive Syk/FLT3 inhibitor
- Inhibits Lyn and Lck
- For research use only
U.S. Pharmacopeia 1MONOIODOAMIODARONE (25 MG)
Monoiodoamiodarone (25 mg) ((2-Butylbenzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3-iodophenyl}methanone)
Medchemexpress LLC Capecitabine 2 3 -d 5g
Capecitabine 2 3 -diacetate (Compound 10b) is the prodrug for the antitumor agent Capecitabine (HY-B0016)[1]
Medchemexpress LLC Salbutamol | 18559-94-9 | MFCD00148978 | 99.5% | 1 ML
Salbutamol (Albuterol) is an orally active, short-acting β2-adrenergic receptor agonist, primarily used in research for bronchospasm in conditions like asthma and COPD. Studies indicate its role in gastric cancer tumorigenesis via the β2-AR/ERK/EMT pathway and its protective effect against Streptozotocin-induced skeletal muscle atrophy in diabetic rats.
- Orally active short-acting β2-adrenergic receptor agonist.
- Used in research for bronchospasm related to asthma and chronic obstructive pulmonary disease.
- Induces EMT, migration, and invasion in gastric cancer cells in vitro.
- Increases tumor growth in nude mice with gastric cancer in vivo.
- Protects against Streptozotocin-induced skeletal muscle atrophy in diabetic rats by enhancing muscle strength, coordination, and antioxidant levels, reducing inflammation and oxidative stress, and improving muscle cellular architecture.
Medchemexpress LLC Fostamatinib (disodium hexahydrate) | 914295-16-2 | 99.5% | 100 MG
Fostamatinib (disodium hexahydrate) is a chemical compound commonly used as a laboratory chemical and for the manufacture of substances. It appears as a white to gray solid with a high purity of 99.5%. It is recommended for sealed storage away from moisture at 4°C, or at -80°C for 6 months (-20°C for 1 month) when in solvent.
- Used in laboratory research
- Suitable for substance manufacturing
- High purity (99.5%)
- Recommended sealed storage at 4°C, away from moisture
- Storage in solvent: -80°C for 6 months, -20°C for 1 month
- Shipping at room temperature if less than 2 weeks
- White to gray solid appearance
Medchemexpress LLC Fostamatinib Disodium | 1025687-58-4 | 98.3% | 200 MG
Fostamatinib Disodium is an oral prodrug of the active compound R406. It acts as an orally available and competitive Syk/FLT3 inhibitor, also demonstrating inhibitory activity against Lyn and Lck. This compound is intended for research purposes only.
- Oral prodrug of R406
- Orally available
- Competitive Syk/FLT3 inhibitor (Ki of 30 nM, IC50 of 41 nM)
- Inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM)
- Intended for research use only
Medchemexpress LLC N-(4-chloro-3-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine | 2803456-91-7 | MFCD00024004 | 50mg
Dacomitinib impurity 16 is an impurity of Dacomitinib (HY-13272)
TARGETMOL CHEMICALS INC OSIMERTINIB 200MG
Also available in 2 mg 5 mg 10 mg 25 mg 100 mg 1000 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Osimertinib (AZD-9291) is a small molecule tyrosine kinase receptor inhibitor and antineoplastic agent that is used in the therapy of selected forms of advanced non-small cell lung cancer (NSCLC). purity: 99%
Medchemexpress LLC Fostamatinib | 901119-35-5 | 99.7% | 200 MG
Fostamatinib (R788) is an oral proagent of the active compound R406. R406 is a competitive Syk/FLT3 inhibitor with a Ki of 30 nM and an IC50 of 41 nM. It also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM).
- Oral proagent of the active compound R406
- Competitive Syk/FLT3 inhibitor
- Inhibits Lyn
- Inhibits Lck
Medchemexpress LLC 3-(4-bromo-7-fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 2438239-34-8 | ≥97.0% | 341.13 g/mol | C13H10BrFN2O3 | 50 MG
Lenalidomide-4-Br-7-fluoro is a synthetic analog of lenalidomide bearing bromine and fluorine substituents on the benzyl ring. Supplied as a solid research-use compound, it is used in chemical biology and medicinal chemistry to probe cereblon engagement and structure-activity relationships. The material is offered at high purity for analytical and biological studies.
- Derivative of lenalidomide with bromo and fluoro substituents.
- Used to study cereblon (CRBN) ligand interactions and degradation pathways.
- Provided as a solid powder suitable for small-scale assays and synthesis.
- High purity appropriate for analytical and biological experiments.
- Available in small pack sizes for research screening workflows.
Cayman Chemical Methocarbamol 50g
An orally bioavailable skeletal muscle relaxant; inhibits the ability of mice to remain on a vertical ladder for 1 minute (ED50 = 15 mg/kg) and decreases forelimb grip strength by 35.9% (500 mg/kg); abolishes femoral nerve-stimulated polysynaptic reflex contractions of the cat tibialis anterior muscle and prolongs the mean refractory period of directly or indirectly stimulated skeletal muscle (200 mg/kg); inhibits human CAI over CAII (IC50s = 70 and ~80,000 μM, respectively)
Medchemexpress LLC Clevudine (L-FMAU) | 163252-36-6 | 99.8% | 260.22 | 50 MG
Clevudine (L-FMAU) is a nucleoside analog of the unnatural L-configuration with potent anti-HBV activity, long half-life, and low toxicity. It acts as a non-competitive inhibitor that binds to the polymerase rather than being incorporated into the viral DNA. Clevudine is also active against cowpox virus respiratory infection in mice.
- Potent anti-HBV activity
- Long half-life
- Low toxicity
- Acts as a non-competitive inhibitor
- Active against cowpox virus respiratory infection in mice